Eribulin mesylate exerts antitumor effects via CD103
Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2023-12-01
|
| Reeks: | OncoImmunology |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
